Adaptive Biotechnologies Corporation

NasdaqGS:ADPT Stock Report

Market Cap: US$1.1b

Adaptive Biotechnologies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ADPT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Nov 24SellUS$1,235Kyle PiskelIndividual248US$4.98
05 Mar 24SellUS$167,007Chad RobinsIndividual48,673US$3.44
05 Mar 24SellUS$53,169Tycho PetersonIndividual15,456US$3.44
05 Mar 24SellUS$135,764Julie RubinsteinIndividual39,070US$3.56
05 Mar 24SellUS$44,629Susan BobulskyIndividual12,991US$3.44
05 Mar 24SellUS$100,994Sharon BenzenoIndividual29,390US$3.44
05 Mar 24SellUS$45,963Stacy TaylorIndividual13,381US$3.44
05 Mar 24SellUS$26,504Kyle PiskelIndividual7,727US$3.43
05 Mar 24SellUS$50,439Francis LoIndividual14,700US$3.44

Insider Trading Volume

Insider Buying: ADPT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ADPT?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders5,738,0153.83%
Hedge Funds53,794,28135.9%
Institutions90,428,24460.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 88.43% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.3%
Viking Global Investors LP
29,993,708US$216.0m0%0.65%
9.76%
Rubric Capital Management LP
14,400,000US$103.7m2.86%1.57%
8.09%
BlackRock, Inc.
11,932,841US$85.9m2.3%no data
7.86%
ARK Investment Management LLC
11,601,134US$83.5m1.66%0.53%
7.21%
The Vanguard Group, Inc.
10,639,440US$76.6m4.03%no data
6.37%
Millennium Management LLC
9,400,573US$67.7m1.49%0.05%
5.24%
Nikko Asset Management Co., Ltd.
7,733,884US$55.7m12.1%0.02%
5.24%
Sumitomo Mitsui Trust Asset Management Co., Ltd.
7,733,884US$55.7m0%0.03%
2.03%
Aristotle Atlantic Partners, LLC
3,001,201US$21.6m0.91%0.43%
1.95%
Massachusetts Financial Services Company
2,881,364US$20.7m-26.4%no data
1.8%
Geode Capital Management, LLC
2,661,878US$19.2m-0.76%no data
1.73%
State Street Global Advisors, Inc.
2,551,785US$18.4m1.95%no data
1.45%
Blue Water Life Science Advisors, LP
2,145,145US$15.4m0%11.03%
1.23%
Chad Robins
1,815,403US$13.1m0%no data
0.96%
Dimensional Fund Advisors LP
1,420,995US$10.2m3.79%no data
0.93%
Goldman Sachs Asset Management, L.P.
1,375,428US$9.9m146%no data
0.88%
Pictet Asset Management Limited
1,301,783US$9.4m-22.6%0.01%
0.86%
Pier Capital, LLC
1,275,885US$9.2m20.9%1.08%
0.75%
Soleus Capital Management, L.P.
1,112,749US$8.0m-35.3%0.53%
0.7%
abrdn plc
1,029,447US$7.4m0%no data
0.69%
Harlan Robins
1,021,180US$7.4m0%no data
0.65%
Northern Trust Global Investments
963,532US$6.9m3.84%no data
0.62%
Charles Schwab Investment Management, Inc.
916,743US$6.6m1.13%no data
0.55%
Point72 Asset Management, L.P.
814,410US$5.9m0%0.01%
0.53%
Bank of America Corporation, Asset Management Arm
777,166US$5.6m-31.6%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 02:00
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Adaptive Biotechnologies Corporation is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Derik de BruinBofA Global Research
Mark MassaroBTIG
Daniel LeonardCredit Suisse